# COPIKTRA

NDC: 73116-225
Generic name: duvelisib
Labeler / Manufacturer: Secura Bio, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20180925

FDA application: NDA211155

## Active ingredients

- DUVELISIB: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73116-225"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73116-225
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e3c5ac56-e1f6-473a-bc73-687836534780